Biotechnologies Assets SA (BST.MC)
EUR 0.3
(2.54%)
EUR 0.3
(2.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 47.73 Thousand | -1.73 Million | -1.5 Million | 8.79 Million | -15.16 Million | -13.02 Million |
| Net Income | 2.32 Million | -204.27 Million | -3.01 Million | -8.45 Million | -9.99 Million | -16.8 Million |
| Depreciation & Amortization | 2.46 Million | 214.77 Million | 2.03 Million | 2.21 Million | 4.3 Million | 2.73 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -477.22 Thousand | -15.45 Million | -496.32 Thousand | 12.27 Million | -9.85 Million | 1.12 Million |
| Other non-cash items | -4.26 Million | 3.22 Million | -22.6 Thousand | 2.75 Million | 384.04 Thousand | -75.11 Thousand |
| Investing Cash Flow | -325.96 Thousand | -211.52 Million | -661.46 Thousand | 44.83 Million | -7.48 Million | -9.69 Million |
| Investments in PPE | -325.96 Thousand | -211.52 Million | -661.46 Thousand | -391.53 Thousand | -7.48 Million | -11.19 Million |
| Acquisitions | - | - | - | -608.67 Thousand | - | - |
| Investment purchases | - | - | - | 387.06 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | 998.9 Thousand | - | 1.5 Million |
| Other Investing Activities | -256.38 Thousand | - | - | 44.45 Million | - | 0.84 |
| Financing Cash Flow | -61 Thousand | 114.74 Million | 3.28 Million | -57.84 Million | 23.49 Million | 24.16 Million |
| Debt repayment | -721.52 Thousand | -81.32 Million | -555.02 Thousand | -57.92 Million | -32.95 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -76.07 Thousand | -8.09 Million | -961.49 Thousand | -15.01 Thousand | - | - |
| Common Stock Issuance | 511.64 Thousand | 151.17 Million | 3 Million | - | - | - |
| Other Financing Activities | -369.77 Thousand | 111.99 Million | 2.75 Million | 100.23 Thousand | 56.44 Million | 24.16 Million |
| Accounts receivables | -1.01 Million | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 18.13 Thousand | 8.01 Million | -1.47 Million | 623.32 Thousand |
| Other working capital | 539.62 Thousand | - | -514.46 Thousand | 4.26 Million | -8.38 Million | 503.04 Thousand |
| Cash at beginning of period | 692.1 Thousand | 167.71 Million | 555.96 Thousand | 4.76 Million | 3.95 Million | 2.5 Million |
| Cash at end of period | 352.87 Thousand | 69.21 Million | 1.67 Million | 555.96 Thousand | 4.76 Million | 3.95 Million |
| Capital Expenditure | -325.96 Thousand | -211.52 Million | -661.46 Thousand | -391.53 Thousand | -7.48 Million | -11.19 Million |
| Effect of forex changes on cash | 0.45 | -1.00 | 0.01 | - | -33.67 Thousand | - |
| Net cash flow / Change in cash | -339.23 Thousand | -98.5 Million | 1.12 Million | -4.21 Million | 818.41 Thousand | 1.44 Million |
| Free Cash Flow | -278.22 Thousand | -213.25 Million | -2.16 Million | 8.4 Million | -22.64 Million | -24.21 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.32 Million | -689.75 Thousand | -689.75 Thousand | 1.47 Million | 1.47 Million | -204.27 Million |
| Depreciation & Amortization | 2.46 Million | 594.35 Thousand | 594.35 Thousand | 638.45 Thousand | 638.45 Thousand | 214.77 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -477.22 Thousand | -234.33 Thousand | -234.33 Thousand | -36.69 Thousand | -36.69 Thousand | -15.45 Million |
| Other non-cash items | -4.26 Million | 821.4 Thousand | 821.4 Thousand | -2.54 Million | -2.54 Million | 3.22 Million |
| Investing Cash Flow | -325.96 Thousand | 108.35 Thousand | 108.35 Thousand | -271.34 Thousand | -271.34 Thousand | -211.52 Million |
| Investments in PPE | -325.96 Thousand | -32.89 Thousand | -32.89 Thousand | -1896.00 | -1896.00 | -211.52 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 141.25 Thousand | 141.25 Thousand | -269.44 Thousand | -269.44 Thousand | - |
| Financing Cash Flow | -61 Thousand | -571.69 Thousand | -571.69 Thousand | 541.19 Thousand | 541.19 Thousand | 114.74 Million |
| Debt repayment | -721.52 Thousand | - | - | - | - | -81.32 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -76.07 Thousand | -17.89 Thousand | -17.89 Thousand | -20.14 Thousand | -20.14 Thousand | -8.09 Million |
| Common Stock Issuance | 511.64 Thousand | - | - | - | - | 151.17 Million |
| Other Financing Activities | -369.77 Thousand | -553.79 Thousand | -553.79 Thousand | 561.33 Thousand | 561.33 Thousand | 111.99 Million |
| Accounts receivables | - | -471.72 Thousand | -471.72 Thousand | -36.69 Thousand | -36.69 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 237.38 Thousand | 237.38 Thousand | - | - | - |
| Cash at beginning of period | 692.1 Thousand | - | - | - | - | 167.71 Million |
| Cash at end of period | 352.87 Thousand | 28.33 Thousand | 28.33 Thousand | -197.95 Thousand | -197.95 Thousand | 69.21 Million |
| Capital Expenditure | -325.96 Thousand | -32.89 Thousand | -32.89 Thousand | -1896.00 | -1896.00 | -211.52 Million |
| Effect of forex changes on cash | 0.45 | - | - | - | - | -1.00 |
| Net cash flow / Change in cash | -339.23 Thousand | 28.33 Thousand | 28.33 Thousand | -197.95 Thousand | -197.95 Thousand | -98.5 Million |
| Free Cash Flow | -278.22 Thousand | 458.77 Thousand | 458.77 Thousand | -469.69 Thousand | -469.69 Thousand | -213.25 Million |
YGR
BTSGIF
2934
6584
4250
TAEE4